Home › Free Stock Grades › DTIL
Precision BioSciences, Inc. (DTIL) Stock Grade
DTIL · Healthcare
D
Market Cap
$80.0M
P/E Ratio
—
Revenue Growth (YoY)
-50.1%
Net Margin
-133.5%
Return on Equity
—
Dividend Yield
None
About Precision BioSciences, Inc.'s fundamentals
Precision BioSciences is a small-cap biotechnology company with a market capitalization of $80 million that is currently unprofitable, reporting a net loss in its latest annual statement with a net margin of -133.5%. The company experienced significant revenue contraction, declining 50.1% year-over-year, indicating substantial challenges in its commercial performance. As a pre-profitability biotech firm, the company does not pay a dividend and traditional valuation metrics like P/E ratio and return on equity are not applicable given its loss-making status.